Issues
While the coronavirus concerns are still high, stocks have recovered their footing, as China has taken steps to stimulate its economy and markets.
The Cabot Global Stocks Explorer portfolio is holding up well, though Luckin Coffee (LK) sold off hard and then sharply rebounded this week. Our emerging markets timer (EEM) is marginally positive, and in an uptrend in the last month.
Today’s recommendation is a leader in fintech with a great growth story, strong numbers and an attractive entry point.
The Cabot Global Stocks Explorer portfolio is holding up well, though Luckin Coffee (LK) sold off hard and then sharply rebounded this week. Our emerging markets timer (EEM) is marginally positive, and in an uptrend in the last month.
Today’s recommendation is a leader in fintech with a great growth story, strong numbers and an attractive entry point.
This month we’re going deep into the world of high-speed sensing and communications with an unknown micro-cap stock specializing in fiber optic technologies.
This isn’t another of those boom-to-bust components manufacturers that crush it when data centers are expanding and fall apart when capex falls. Rather, it’s a company that specializes in fiber optics for industrial, transportation and construction applications, such as in airplanes, vehicles, buildings and space stations.
It’s not a low-risk investment. But the potential is huge – if management can execute on its growth plan.
Zoom into the February Issue for all the high-speed details!
This isn’t another of those boom-to-bust components manufacturers that crush it when data centers are expanding and fall apart when capex falls. Rather, it’s a company that specializes in fiber optics for industrial, transportation and construction applications, such as in airplanes, vehicles, buildings and space stations.
It’s not a low-risk investment. But the potential is huge – if management can execute on its growth plan.
Zoom into the February Issue for all the high-speed details!
Today’s featured stocks reported fourth quarter results this morning; we have a new addition to the Growth & Income Portfolio; which could deliver quick capital gains when they report earnings; and another company which gave an informative presentation at the recent Needham Growth Conference.
I also discuss the coronavirus, which could easily cause stock market turbulence through April, even if the virus dissipates quickly.
I also discuss the coronavirus, which could easily cause stock market turbulence through April, even if the virus dissipates quickly.
Today’s recommendation is a British outfit that, as its stock symbol suggests, is thriving thanks to offerings that help workplace teams plan, interact, engage, track progress and more, all of which is becoming more difficult as workplaces become more mobile.
The much-needed market correction is now two weeks old and thus still quite young, but as it evolves, and we adapt to its actions, we will continue to cultivate a portfolio of the best stocks by selling our laggards and holding our leaders.
Last week that meant selling four stocks, but this week it means only a couple of downgrades to hold, along with one upgrade to buy.
As for this week’s recommendation, it’s a big old high-tech company that is currently range bound, but whose valuation and chart are attractive, so long-term investment should work out well. Plus it pays a dividend of 4.3%.
Details in the issue.
Last week that meant selling four stocks, but this week it means only a couple of downgrades to hold, along with one upgrade to buy.
As for this week’s recommendation, it’s a big old high-tech company that is currently range bound, but whose valuation and chart are attractive, so long-term investment should work out well. Plus it pays a dividend of 4.3%.
Details in the issue.
Current Market OutlookThe market rebounded nicely today, and we won’t pooh-pooh that, as a show of support is always a positive. That said, we need to see more to conclude the sellers have left the building—the intermediate-term trend, for instance, remains on the fence, and while there are no sure things, it’s likely the market will need more than six days to consolidate a four-month advance. Bigger picture, nothing has changed our view that this is a bull market, though, so we’re certainly not advising you to become overly defensive, but we’d stick with the plan of holding some cash, keeping your weakest stock or two on a tight leash and being careful on the buy side, especially when it comes to buying on strength (most moves to new highs are being met with selling). Our Market Monitor will remain at 6 for now, though we’re obviously watching things closely.
Believe it or not, many stocks did well last week, and today’s list features some of them. Our Top Pick is Yeti (YETI), which is set up nicely ahead of earnings in two weeks; you could nibble here, or just wait until you see a powerful breakout.
| Stock Name | Price | ||
|---|---|---|---|
| Atlassian (TEAM) | 182.16 | ||
| Dynatrace (DT) | 36.59 | ||
| Fortune Brands Home & Security (FBHS) | 81.02 | ||
| Franco-Nevada (FNV) | 125.51 | ||
| Momenta Pharma (MNTA) | 31.63 | ||
| Penn National Gaming (PENN) | 45.38 | ||
| PulteGroup (PHM) | 45.93 | ||
| ServiceNow (NOW) | 341.86 | ||
| Tandem Diabetes (TNDM) | 74.77 | ||
| Yeti Holdings (YETI) | 42.80 |
With the market near record highs, many stocks are trading well above the $1,000/share price level. Investors tend to dismiss stocks with basement-level prices, so we explored this maligned group in search of neglected value.
In this issue, we look at the several of our recommended stocks in this range.
In this issue, we look at the several of our recommended stocks in this range.
The long-awaited pullback appears to have arrived, with fears and uncertainty surrounding the coronavirus and its impact on economic growth bringing out the sellers; our Cabot Tides, in fact, are now on the fence. In the near-term, the odds favor some more pain being dished out, not necessarily because of the virus, but as the market consolidates its strong four-month advance. Big picture, though, this is still a bull market, so while we’ve trimmed a bit, we’re aiming to hold our strong, profitable stocks, thinking higher highs are likely once this pullback does its work.
In the Model Portfolio, we took partial profits on DocuSign and ProShares S&P 500 Fund earlier this week, which lifted our cash position to around 20%. And from here, we’ll just take it as it comes, as we explain in tonight’s issue.
In the Model Portfolio, we took partial profits on DocuSign and ProShares S&P 500 Fund earlier this week, which lifted our cash position to around 20%. And from here, we’ll just take it as it comes, as we explain in tonight’s issue.
Updates
Continue to play things halfway. The market has made solid progress during the past two weeks, increasing the odds that a low has been formed. That said, few growth stocks have kicked into gear, and the longer-term trend is still down. We continue to fine-tune our watch list, but tonight, we’re standing pat in the Model Portfolio with five stocks and a cash position near 52%.
Given the generally improving health of the broad market, I’m putting General Motors (GM) and CVS Health (CVS) back on Buy today. We have no other changes to the portfolio.
I’m changing the stock rating on BorgWarner (BWA) to Hold, E*Trade Financial (ETFC) to Buy, H&R Block (HRB) to Hold and Vulcan Materials (VMC) to Hold. Quarterly earnings were reported last week by Big Lots and H&R Block. There’s dividend news on Big Lots (BIG), and there’s stock repurchase news on Big Lots (BIG), Delta Air Lines (DAL) and H&R Block (HRB).
The Cabot Emerging Markets Timer is flashing a robust buy signal. So, following our rules, we’re edging steadily back into the market, increasing our exposure to strong growth stocks. Today, we are upgrading SSW from Hold to Buy and initiating positions in SBGL and TLK with recommendations to Buy a Half position of each stock.
The market has maintained its intermediate-term uptrend, and you can continue to become more invested, cautiously. Today we’re putting Target (TGT) back on Buy after the retailer reported improvement in some key metrics in the latest quarter.
It was a good week despite the ongoing rumblings of oil-related debt defaults, talk of the perils of a negative interest rate environment and relatively lackluster growth from companies that have reported thus far.
Remain defensive but keep your eyes open. Our Cabot Tides are toying with a buy signal, though the past couple of days have delayed it. Because of that, we’re sticking with our three remaining stocks and a cash position around 75% tonight, but we have our shopping list ready should we get a clear green light in the days ahead.
Last week, The Priceline Group (PCLN) reported fourth-quarter 2015 results that surpassed market earnings per share (EPS) expectations, while Boise Cascade (BCC) reported fourth-quarter 2015 results that disappointed the market. I’m raising the ratings on Carnival (CCL), D.R. Horton (DHI) and Royal Carribean Cruises (RCL) to Buy. I’m lowering the rating on Boise Cascade (BCC) to Hold.
The market is still serving up its fair share of surprises, both to the upside and to the downside. We’ve experienced a few of both in our portfolio, and over the last two weeks, we’ve stepped aside from three stocks (my rationale was detailed in the Special Bulletins). This week, two of our stocks reported, and I moved one to Sell.
The Cabot Emerging Markets Timer has edged its way up to a new buy signal. While we want to be cautious until we get confirmation of this uptrend, we will increase our exposure slightly. We will fill our position in TAL Education, changing its rating from Hold a Half to Buy.
Our portfolio is hunkered down in a pretty conservative stance and we’re selling the rest of our Novo Nordisk (NVO) position today and moving our PowerShares Preferred ETF (PGX) to Hold. We have no other rating changes today.
Global stock, bond, oil and gold markets continue to bounce around as investors look for trends that signal a re-entry into stocks. Today, I’d like to review facts vs. fiction, in order to give us a little more peace as we live through the stock market correction.
Alerts
Our first idea is an airline that beat Wall Street’s earnings forecasts by $0.33 last quarter.
In the past 30 days, 15 analysts have increased their earnings estimates for this drug store/pharmacy chain.
The major indexes did well on Friday, with the Dow up 136 points and the Nasdaq up 9 points. But growth stocks were once again hit relatively hard with another few breaking intermediate-term support. One our positions broke down after a good-not-great quarterly report and it’s time to sell.
Coverage of the shares of this optoelectronics maker were recently initiated at Cowen & Co. with an ‘Outperform’ rating. Wall Street is forecasting annual growth of 30.8% over the next five years for the company.
We have one Sell today and one stock that moves from Strong Buy to Hold
Our second recommendation is a short sale.
Our first pick today just received an upgrade from Morgan Stanley, to ‘Overweight’.
Five of the stocks in the portfolio have reported earnings.
Six of our stocks reported earnings recently.
The shares of this Chinese education company were just initiated at Jefferies with a ‘Buy’ rating.
This bank is involved in several M&A transactions, and its stock appears to be heavily discounted.
Declining markets tend to bring on attacks by short-selling specialists, and today that’s what has happened to GDS Holdings (GDS)
Portfolios
Strategy
A few Cabot Options Trader subscribers have asked me about ways to protect gains in their portfolios, so I thought I would write to everyone with a couple of strategies using options to hedge your portfolio.
A subscriber recently asked me if I keep a journal of my trades. Many traders keep journals so they can look back at their trades and evaluate what they did right and what they did wrong.
Want to know how the big institutional investors use options? Here is an example of how one trader spent $132 million on three technology stocks.
Options trading has its own vernacular. To know how to do it, you need to know what every options term means. Here are some of the basics.
Our Cabot Top Ten Trader’s market timing system consists of two parts—one based on the action of three select, growth-oriented market indexes, and the other based on the action of the fast-moving stocks Cabot Top Ten features.